BECTON DICKINSON INFUSION THERAPY SYSTEMS INC has a total of 19 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology and measurement are ATILA BIOSYSTEMS INC, GUANGDONG ASCENDAS GENOMICS TECH CO LTD and SHANGHAI CHROMYSKY MEDICAL RES CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 2 | |
#4 | United Kingdom | 1 | |
#5 | Japan | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Huletsky Ann | 12 |
#2 | Giroux Richard | 12 |
#3 | Roger-Dalbert Celine | 2 |
#4 | Courjal Frank | 2 |
#5 | Jean Veronique | 2 |
#6 | Duteaud Isabelle | 2 |
#7 | Savoye Chantal | 2 |
#8 | Guillot Melanie | 2 |
#9 | Lippe Catherine | 2 |
#10 | Godfrin Yann | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013276986A1 | Detection of Staphylococcus Aureus and identification of methicillin-resistant Staphylococcus Aureus | |
AU2013200217A1 | Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx | |
GB201317805D0 | Method and internal control composition for determining the efficacy of enzymatic cell lysis |